P2RY12 and chronic kidney disease: To address this question, we performed a retrospective study to determine whether sepsis in nondialysis patients with CKD was better controlled by the potent P2Y12-Is prasugrel or ticagrelor than by the less potent P2Y12-I clopidogrel.